The insider sales are too small to warrant a bearish read, monitor for any larger cluster or a Form 4 filing from the CEO/Chairman. The historical underperformance of ZLAB reports suggests caution on any directional call; focus on upcoming pipeline catalysts or earnings for the next material move.
ZLAB drugs
ZLAB drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 14 $25.90entry
- T+1 · 3mo ago −1.00%α −0.53% · $25.64
- T+5 · 3mo ago +0.42%α +1.79% · $26.01
- T+20 · 2mo ago −5.10%α −3.11% · $24.58
- T+60 · 8d ago +3.71%α +6.75% · $26.86
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two Zai Lab insiders, including CFO Chen Yajing and Director Lis William, sold a combined $228K in open-market sales over a 2-day window. The total value is only ~0.008% of ZLAB's $2.9B market cap, making this a trivial, routine cluster with no material signal.
Key Financial Metrics
Key Facts
- CFO Chen Yajing sold 619 shares for $15,475 on 2026-08-11
- Director Lis William sold 8,506 shares for $212,650 on 2026-08-12
- Total cluster value of $228K represents ~0.008% of ZLAB's $2.9B market cap
- Both sales were open-market transactions, not 10b5-1 plan sales
- No insider buying in the cluster to offset the selling
Financial Impact
Total insider sales of $228K, immaterial relative to $2.9B market cap
Risk Factors
- Insider selling could accelerate if management becomes more bearish on near-term pipeline milestones
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ZLAB-1786691863091 |
Track record
23 reports on ZLAB
3 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +13.13% at T+20 after the May 7, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry price pending
- Nov 5, 202611d ago 8-K Neutral 5/10 Entry $22.60 to $25.48 Now $23.47 +3.85% ▲ +12.74% +12.43% vs SPY
- Oct 23, 202624d ago 8-K Bullish 6/10 Entry $24.03 to $24.34 Now $23.47 −2.33% ▲ +1.29% +0.58% vs SPY
- Aug 21, 202612w ago Insider Cluster Neutral 2/10 Entry $25.64 to $26.17 Now $23.47 −8.46% ▲ +2.07% +1.75% vs SPY
- Aug 13, 202613w ago Insider Cluster Neutral 2/10 Entry $25.90 to $25.64 Now $23.47 −9.38% ▼ −1.00% −0.53% vs SPY
- Aug 13, 202613w ago Insider Cluster Neutral 2/10 Viewing Entry $25.90 to $25.64 Now $23.47 −9.38% ▼ −1.00% −0.53% vs SPY
- Aug 12, 202613w ago 144 Neutral 2/10 Entry $25.49 to $26.03 Now $23.47 −7.92% ▲ +2.12% +1.42% vs SPY
- Jul 1, 202619w ago Insider Cluster Neutral 2/10 Entry $19.12 to $19.08 Now $23.47 +22.75% ▼ −0.21% −1.08% vs SPY
- Jun 29, 202620w ago Insider Cluster Neutral 3/10 Entry $19.00 to $19.15 Now $23.47 +23.53% ▲ +0.79% +0.92% vs SPY
- Jun 11, 202622w ago Institutional Cluster Bearish 5/10 Entry $17.64 to $17.07 Now $23.47 −33.05% ▲ +3.23% +3.77% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers